Free Trial

Lantern Pharma (LTRN) News Today

Lantern Pharma logo
$2.87 -0.03 (-1.03%)
Closing price 04:00 PM Eastern
Extended Trading
$2.87 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LTRN Latest News

Brokers Set Expectations for Lantern Pharma FY2025 Earnings
Zacks Small Cap Comments on Lantern Pharma Q2 Earnings
LTRN: First Quarter 2025 Financial Results
Lantern Pharma initiated with a Buy at Lake Street
LTRN: 2024 Financial Results
Preview: Lantern Pharma's Earnings
LTRN: M&A Illuminates GBM Value
Lantern Pharma doses first patient in LP-300 trial expansion cohort
LTRN: Pediatric Rare Cancer in Focus
Lantern Pharma Advances AI-Driven Cancer Therapies
Get Lantern Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LTRN and its competitors with MarketBeat's FREE daily newsletter.

LTRN Media Mentions By Week

LTRN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LTRN
News Sentiment

0.94

1.03

Average
Medical
News Sentiment

LTRN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LTRN Articles
This Week

8

1

LTRN Articles
Average Week

Get Lantern Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LTRN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LTRN) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners